Latest Kaiser Health News Stories
The military is called to action to battle the pandemic, even as the numbers of people infected among its ranks and veterans climb amid a shortage of doctors and nurses.
Revenue is way down for primary care, specialty physicians and some hospitals as patients avoid non-urgent visits. Practices small and large are doling out layoffs and furloughs to staff.
Many of the nation’s safety-net clinics for low-income patients are having to turn their model of care upside down overnight to deal with the realities of the pandemic — a challenge both financially and logistically. Federal funding is on the way.
It’s hard to manage chronic conditions without a steady source of healthy food. That’s why more health care providers are setting up food pantries — right inside hospitals and clinics.
It’s open enrollment season for health insurance. And choosing the best plan is tricky whether you have to buy insurance on your own or just figure out which plan to sign up for at work. Here’s what you need to know.
How are critical medical services interrupted by the loss of power and what can hospitals and clinics do to minimize the impact? This Q&A will give you some answers.
Obria, a Christian medical chain, was awarded federal family planning funds for its California clinics for the first time this year. Clinics receiving Title X funds are expected to treat and prevent sexually transmitted diseases. Obria’s prohibition against condoms means its prevention efforts rest on abstinence, even as STD rates surge.
The legal fight over the Trump administration’s new rule barring health clinics that receive federal family planning grants from referring women for abortion services played out before a divided federal appeals court Monday. Here are key takeaways.
Simple alterations — like better signs, seating, parking or door design — can make it easier for older patients to navigate health care facilities. Here are several changes doctors’ offices, clinics and hospitals could make.
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
The Trump administration’s policy shift on Title X family planning funds is likely to make birth control harder to get and more expensive for low-income women. It will also shift funds from organizations like Planned Parenthood to the Obria Group, which does not give women hormonal contraceptives or condoms in its clinics.
An encounter with a cat led to rabies shots and provided yet another illustration of how confusing, contrary and expensive the American health care system is.
California’s stem cell agency, created by a $3 billion bond measure 15 years ago, is almost out of money. Its supporters plan to ask voters for even more funding next year, even though no agency-funded treatments have been approved for widespread use.
A small health center in Goshen, Ind., near the border with Michigan, puts “listening to patients’ stories” first. “The rest is housekeeping.”
Tennessee company’s Medicare billings for urine tests were examined by Kaiser Health News in 2017.
Regenexx, which runs a string of clinics, says stem cell injections can save employers a lot of money, but critics say there’s no proof.
Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner to discuss the Trump administration’s efforts to curtail federally funded research using fetal tissue, the backlash from former Vice President Joe Biden’s support for the anti-abortion Hyde Amendment and how health policy intersects with both trade and immigration policy.
While Missouri’s final abortion clinic may stop providing the procedure this week, women in the state had already been seeking care in neighboring states as regulations increasingly limited abortion access.
Under the rule that took effect this year, Medicare will lower payments for clinic visits performed at hospital-owned facilities to a rate that is equivalent to what it pays an independent doctor. Federal officials expect the move will save the government $380 million this year.
Critics are concerned about the explosion in controversial stem cell procedures offered by clinics — and, increasingly, respected hospitals.